Clinical Trial Update: Cortical Metrics in Intervention Trials With Autism Spectrum Disorders [Phase 2, Phase 3]

View source ↗

Summary

The clinical trial update notes that the Phase 2/3 cortical metrics intervention trials for autism spectrum disorder have been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Snippet

Sponsor: Duke University | Conditions: Autism Spectrum Disorders | Phase 2, Phase 3 | Status: WITHDRAWN